The effect of high-intensity focused ultrasound guided by magnetic resonance therapy on obstetrical outcomes in patients with uterine fibroids – experiences from the main Polish center and a review of current data

References

• Stewart EA. Uterine fibroids. Lancet. 2001;357:293–298.
   PubMed Web of Science ®Google Scholar
• Stewart EA, Laughlin-Tommaso SK, Catherino WH, et al. Uterine fibroids. Nat Rev Dis Primers. 2016;2:16041–16043.
   PubMed Web of Science ®Google Scholar
• Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 2007;87:725–736.
   PubMed Web of Science ®Google Scholar
• Stewart EA, Cookson CL, Gandolfo RA, et al. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124:1501–1512.
   PubMed Web of Science ®Google Scholar
• Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22:571–588.
   PubMed Web of Science ®Google Scholar
• Soliman AM, Yang H, Du EX, et al. The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013. Am J Obstet Gynecol. 2015;213:141–160.
   PubMed Web of Science ®Google Scholar
• Soliman AM, Margolis MK, Castelli-Haley J, et al. Impact of uterine fibroid symptoms on health-related quality of life of US women: evidence from a cross-sectional survey. Curr Med Res Opin. 2017;33:1971–1978.
   PubMed Web of Science ®Google Scholar
• Fuldeore MJ, Soliman AM. Patient-reported prevalence and symptomatic burden of uterine fibroids among women in the United States: findings from a cross-sectional survey analysis. Int J Womens Health. 2017;9:403–411.
   PubMed Web of Science ®Google Scholar
• Al-Hendy A, Myers ER, Stewart E. Uterine fibroids: burden and unmet medical need. Semin Reprod Med. 2017;35:473–480.
   PubMed Web of Science ®Google Scholar
• Marsh EE, Al-Hendy A, Kappus D, et al. Burden, prevalence, and treatment of uterine fibroids: a survey of U.S. women. J Womens Health (Larchmt). 2018;27:1359–1367.
   PubMed Web of Science ®Google Scholar
• Purohit P, Vigneswaran K. Fibroids and infertility. Curr Obstet Gynecol Rep. 2016;5:81–88.
   PubMed Web of Science ®Google Scholar
• Cardozo ER, Clark AD, Banks NK, et al. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206:211.e1–9.
   PubMed Web of Science ®Google Scholar
• Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update. 2016;22:665–686.
   PubMed Web of Science ®Google Scholar
• Laughlin-Tommaso SK, Jacoby VL, Myers ER. Disparities in fibroid incidence, prognosis, and management. Obstet Gynecol Clin North Am. 2017;44:81–94.
   PubMed Web of Science ®Google Scholar
• Thubert T, Foulot H, Vinchant M, et al. Surgical treatment: myomectomy and hysterectomy; endoscopy: a major advancement. Best Pract Res Clin Obstet Gynaecol. 2016;34:104–121.
   PubMed Web of Science ®Google Scholar
• Donnez J, Courtoy GE, Dolmans MM. Fibroid management in premenopausal women. Climacteric. 2019;22:27–33.
   PubMed Web of Science ®Google Scholar
• Balasch J, Gratacos E. Delayed childbearing: effects on fertility and the outcome of pregnancy. Curr Opin Obstet Gynecol. 2012;24:187–193.
   PubMed Web of Science ®Google Scholar
• Guo XC, Segars JH. The impact and management of fibroids for fertility: an evidence-based approach. Obstet Gynecol Clin North Am. 2012;39:521–533.
   PubMed Web of Science ®Google Scholar
• Donnez J, Arriagada P, Donnez O, et al. Emerging treatment options for uterine fibroids. Expert Opin Emerg Drugs. 2018;23:17–23.
   PubMed Web of Science ®Google Scholar
• King R, Overton C. Management of fibroids should be tailored to the patient. Practitioner. 2011;255:19–23.
   PubMedGoogle Scholar
• Faustino F, Martinho M, Reis J, et al. Update on medical treatment of uterine fibroids. Eur J Obstet Gynecol Reprod Biol. 2017;216:61–68.
   PubMed Web of Science ®Google Scholar
• Gambacorti-Passerini Z, Gimovsky AC, Locatelli A, et al. Trial of labor after myomectomy and uterine rupture: a systematic review. Acta Obstet Gynecol Scand. 2016;95:724–734.
   PubMed Web of Science ®Google Scholar
• Parker WH, Einarsson J, Istre O, et al. Risk factors for uterine rupture after laparoscopic myomectomy. J Minim Invasive Gynecol. 2010;17:551–554.
   PubMed Web of Science ®Google Scholar
• Ali M, Chaudhry ZT, Al-Hendy A. Successes and failures of uterine leiomyoma drug discovery. Expert Opin Drug Discov. 2018;13:169–177.
   PubMed Web of Science ®Google Scholar
• Ciebiera M, Lukaszuk K, Meczekalski B, et al. Alternative oral agents in prophylaxis and therapy of uterine fibroids-an up-to-date review. Int J Mol Sci. 2017;18:pii: E2586.
   Web of Science ®Google Scholar
• Ciebiera M, Wlodarczyk M, Ciebiera M, et al. Vitamin D and uterine fibroids-review of the literature and novel concepts. Int J Mol Sci. 2018;19:pii: E2051.
   Web of Science ®Google Scholar
• Ciebiera M, Męczekalski B, Łukaszuk K, et al. Potential synergism between ulipristal acetate and vitamin D3 in uterine fibroid pharmacotherapy - 2 case studies. Gynecol Endocrinol. 2019. DOI: 10.1080/09513590.2018.1550062
   PubMed Web of Science ®Google Scholar
• Kashani BN, Centini G, Morelli SS, et al. Role of medical management for uterine leiomyomas. Best Pract Res Clin Obstet Gynaecol. 2016;34:85–103.
   PubMed Web of Science ®Google Scholar
• Donnez J, Arriagada P, Marciniak M, et al. Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development program. Expert Opin Drug Saf. 2018;17:1225–1232.
   PubMed Web of Science ®Google Scholar
• Stepniak A. Uterine artery embolization in the treatment of symptomatic fibroids - state of the art. Prz Menopauzalny. 2018;17:141–143.
   PubMedGoogle Scholar
• van der Kooij SM, Ankum WM, Hehenkamp WJ. Review of nonsurgical/minimally invasive treatments for uterine fibroids. Curr Opin Obstet Gynecol. 2012;24:368–375.
   PubMed Web of Science ®Google Scholar
• Sieron D, Wiggermann P, Skupinski J, et al. Uterine artery embolisation and magnetic resonance-guided focused ultrasound treatment of uterine fibroids. Pol J Radiol. 2011;76:37–39.
   PubMedGoogle Scholar
• Stewart EA, Gostout B, Rabinovici J, et al. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol. 2007;110:279–287.
   PubMed Web of Science ®Google Scholar
• LeBlang SD, Hoctor K, Steinberg FL. Leiomyoma shrinkage after MRI-guided focused ultrasound treatment: report of 80 patients. AJR Am J Roentgenol. 2010;194:274–280.
   PubMed Web of Science ®Google Scholar
• Mashiach R, Inbar Y, Rabinovici J, et al. Outcome of magnetic resonance-guided focused ultrasound surgery (MRgFUS) for FIGO class 1 fibroids. Eur J Obstet Gynecol Reprod Biol. 2018;221:119–122.
   PubMed Web of Science ®Google Scholar
• Peregrino PF, Messina ML, Simões RS, et al. Review of magnetic resonance-guided focused ultrasound in the treatment of uterine fibroids. Clinics (Sao Paulo). 2017;72:637–641.
   PubMed Web of Science ®Google Scholar
• Lozinski T, Filipowska J, Gurynowicz G, et al. Non-invasive therapeutic use of High-intensity focused ultrasound (HIFU) with 3 tesla magnetic resonance imaging in women with symptomatic uterine fibroids. Ginekol Pol. 2017;88:497–503.
   PubMed Web of Science ®Google Scholar
• Xie B, Zhang C, Xiong C, et al. High intensity focused ultrasound ablation for submucosal fibroids: A comparison between type I and type II. Int J Hyperthermia. 2015;31:593–599.
   PubMed Web of Science ®Google Scholar
• Quinn SD, Gedroyc WM. Thermal ablative treatment of uterine fibroids. Int J Hyperthermia. 2015;31:272–279.
   PubMed Web of Science ®Google Scholar
• Ji Y, Hu K, Zhang Y, et al. High-intensity focused ultrasound (HIFU) treatment for uterine fibroids: a meta-analysis. Arch Gynecol Obstet. 2017;296:1181–1188.
   PubMed Web of Science ®Google Scholar
• Gizzo S, Saccardi C, Patrelli TS, et al. Magnetic resonance-guided focused ultrasound myomectomy: safety, efficacy, subsequent fertility and quality-of-life improvements, a systematic review. Reprod Sci. 2014;21:465–476.
   PubMed Web of Science ®Google Scholar
• Beck A, David M, Kroncke T. Magnetic resonance-guided focused ultrasound for treatment of myomas - results of the first radiology-gynaecology experts meeting. Geburtshilfe Frauenheilkd. 2014;74:430–432.
   PubMed Web of Science ®Google Scholar
• Chen J, Chen W, Zhang L, et al. Safety of ultrasound-guided ultrasound ablation for uterine fibroids and adenomyosis: a review of 9988 cases. Ultrason Sonochem. 2015;27:671–676.
   PubMed Web of Science ®Google Scholar
• Stanford Health Care. Risks of the MRgFUS procedure. 2019. [cited 2019 Mar 1]. Available from: https://stanfordhealthcare.org/medical-treatments/m/mr-guided-focused-ultrasound/complications.html
   Google Scholar
• Yin N, Hu L, Xiao ZB, et al. Factors influencing thermal injury to skin and abdominal wall structures in HIFU ablation of uterine fibroids. Int J Hyperthermia. 2018;34:1298–1303.
   PubMed Web of Science ®Google Scholar
• Machtinger R, Inbar Y, Cohen-Eylon S, et al. MR-guided focus ultrasound (MRgFUS) for symptomatic uterine fibroids: predictors of treatment success. Hum Reprod. 2012;27:3425–3431.
   PubMed Web of Science ®Google Scholar
• Kroncke T, David M, Magnetic resonance guided focused ultrasound for fibroid treatment - results of the second radiological gynecological expert meeting. Geburtshilfe Frauenheilkd. 2015;75:436–438.
   PubMed Web of Science ®Google Scholar
• Milazzo GN, Catalano A, Badia V, et al. Myoma and myomectomy: poor evidence concern in pregnancy. J Obstet Gynaecol Res. 2017;43:1789–1804.
   PubMed Web of Science ®Google Scholar
• Kumakiri J, Kikuchi I, Kitade M, et al. Association between uterine repair at laparoscopic myomectomy and postoperative adhesions. Acta Obstet Gynecol Scand. 2012;91:331–337.
   PubMed Web of Science ®Google Scholar
• Schlesinger D, Benedict S, Diederich C, et al. MR-guided focused ultrasound surgery, present and future. Med Phys. 2013;40:080901.
   PubMed Web of Science ®Google Scholar
• Rabinovici J, David M, Fukunishi H, et al. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril. 2010;93:199–209.
   PubMed Web of Science ®Google Scholar
• Zou M, Chen L, Wu C, et al. Pregnancy outcomes in patients with uterine fibroids treated with ultrasound-guided high-intensity focused ultrasound. BJOG. 2017;124:30–35.
   PubMed Web of Science ®Google Scholar
• Funaki K, Fukunishi H, Funaki T, et al. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images. Am J Obstet Gynecol. 2007;196:184.e1–6.
   PubMedGoogle Scholar
• Cline HE, Hynynen K, Watkins RD, et al. Focused US system for MR imaging-guided tumor ablation. Radiology. 1995;194:731–737.
   PubMed Web of Science ®Google Scholar
• National Institute of Health and Care Excellence (NICE). Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroids. 2011. [1.03.2019]. Available from: https://www.nice.org.uk/guidance/ipg413
   Google Scholar
• Gorny KR, Borah BJ, Weaver AL, et al. Clinical predictors of successful magnetic resonance-guided focused ultrasound (MRgFUS) for uterine leiomyoma. J Ther Ultrasound. 2013;1:15.
   PubMedGoogle Scholar
• Abdullah B, Subramaniam R, Omar S, et al. Magnetic resonance-guided focused ultrasound surgery (MRgFUS) treatment for uterine fibroids. Biomed Imaging Interv J. 2010;6:e15.
   PubMedGoogle Scholar
• He M, Jacobson H, Zhang C, et al. A retrospective study of ultrasound-guided high intensity focussed ultrasound ablation for multiple uterine fibroids in South Africa. Int J Hyperthermia. 2018;34:1304–1310.
   PubMed Web of Science ®Google Scholar
• Zepiridis LI, Grimbizis GF, Tarlatzis BC. Infertility and uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016;34:66–73.
   PubMed Web of Science ®Google Scholar
• Carranza-Mamane B, Havelock J, Hemmings R, et al. The management of uterine fibroids in women with otherwise unexplained infertility. J Obstet Gynaecol Can. 2015;37:277–285.
   PubMed Web of Science ®Google Scholar
• Simms-Stewart D, Fletcher H. Counselling patients with uterine fibroids: a review of the management and complications. Obstet Gynecol Int. 2012;2012:1.
   Google Scholar
• Cheung VY, Lam TP, Jenkins CR, et al. Ovarian reserve after ultrasound-guided high-intensity focused ultrasound for uterine fibroids: preliminary experience. J Obstet Gynaecol Can. 2016;38:357–361.
   PubMed Web of Science ®Google Scholar
• Bohlmann MK, Hoellen F, Hunold P, et al. High-intensity focused ultrasound ablation of uterine fibroids - potential impact on fertility and pregnancy outcome. Geburtshilfe Frauenheilkd. 2014;74:139–145.
   PubMed Web of Science ®Google Scholar
• Hocquelet A, Denis de Senneville B, Frulio N, et al. Magnetic resonance texture parameters are associated with ablation efficiency in MR-guided high-intensity focussed ultrasound treatment of uterine fibroids. Int J Hyperthermia. 2016;33:142–149.
   PubMed Web of Science ®Google Scholar
• Liu Z, Gong C, Liu Y, et al. Establishment of a scoring system for predicting the difficulty level of high-intensity focussed ultrasound ablation of uterine fibroids. Int J Hyperthermia. 2018;34:77–86.
   PubMed Web of Science ®Google Scholar
• Lozinski T, Filipowska J, Krol P, et al. Oxytocin administration in high-intensity focused ultrasound treatment of myomata. Biomed Res Int. 2018;2018:1.
   Web of Science ®Google Scholar
• Donnez J, Jadoul P. What are the implications of myomas on fertility? A need for a debate? Hum Reprod. 2002;17:1424–1430.
   PubMed Web of Science ®Google Scholar
• Somigliana E, Vercellini P, Daguati R, et al. Fibroids and female reproduction: a critical analysis of the evidence. Hum Reprod Update. 2007;13:465–476.
   PubMed Web of Science ®Google Scholar
• Eun DS, K, Choi Y, Oh Y, et al. Pregnancy outcome after laparoscopic myomectomy for large submucosal myomatas. J Minim Invasive Gynecol. 2012;19:S176.
   PubMed Web of Science ®Google Scholar
• Sangha R, Strickler R, Dahlman M, et al. Myomectomy to conserve fertility: seven-year follow-up. J Obstet Gynaecol Can. 2015;37:46–51.
   PubMed Web of Science ®Google Scholar
• Tian YC, Long TF, Dai YM. Pregnancy outcomes following different surgical approaches of myomectomy. J Obstet Gynaecol Res. 2015;41:350–357.
   PubMed Web of Science ®Google Scholar
• Mohr-Sasson A, Machtinger R, Mashiach R, et al. Long-term outcome of MR-guided focused ultrasound treatment and laparoscopic myomectomy for symptomatic uterine fibroid tumors. Am J Obstet Gynecol. 2018;219:375.e1–e7.
   Web of Science ®Google Scholar
• Chen J, Li Y, Wang Z, et al. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study. BJOG. 2018;125:354–364.
   PubMed Web of Science ®Google Scholar
• Li JS, Wang Y, Chen JY, et al. Pregnancy outcomes in nulliparous women after ultrasound ablation of uterine fibroids: a single-central retrospective study. Sci Rep. 2017;7:3977.
   PubMed Web of Science ®Google Scholar
• Berman JM, Bolnick JM, Pemueller RR, et al. Reproductive outcomes in women following radiofrequency volumetric thermal ablation of symptomatic fibroids. A retrospective case series analysis. J Reprod Med. 2015;60:194–198.
   PubMed Web of Science ®Google Scholar
• Clark NA, Mumford SL, Segars JH. Reproductive impact of MRI-guided focused ultrasound surgery for fibroids: a systematic review of the evidence. Curr Opin Obstet Gynecol. 2014;26:151–161.
   PubMed Web of Science ®Google Scholar
• Liu X, Xue L, Wang Y, et al. Vaginal delivery outcomes of pregnancies following ultrasound-guided high-intensity focused ultrasound ablation treatment for uterine fibroids. Int J Hyperthermia. 2018;35:510–517.
   PubMed Web of Science ®Google Scholar
• Sizzi O, Rossetti A, Malzoni M, et al. Italian multicenter study on complications of laparoscopic myomectomy. J Minim Invasive Gynecol. 2007;14:453–462.
   PubMed Web of Science ®Google Scholar